• TEL: 0086-13083697781

sphs nasdaq

Get Price

We can supply you need sphs nasdaq.

AMPE Ampio Pharmaceuticals, Inc Stock Price and

Nov 27, 2020 · Real-time trade and investing ideas on Ampio Pharmaceuticals, Inc AMPE from the largest community of traders and investors. Revenue, EPS, & Dividend - Sophiris Bio, Inc. (SPHS Mar 06, 2020 · Sophiris Bio, Inc. (SPHS) Revenue, Earnings Per Share (EPS), & Dividend Get free financial information for Sophiris Bio, Inc. including revenue, earnings per share (EPS), and company dividend at NASDAQ

SOPHIRIS BIO INC (SPHS) Latest Stock News & Headlines

Nasdaq Futures 12,099.50 +23.50 (+0.19%) COMING UP. Subscribe to Premium to view Fair Value for SPHS. Learn more. View details. Research that delivers an independent perspective, consistent SOPHIRIS BIO INC (SPHS) Stock Forum & Discussion - Yahoo By David Bautz, PhD NASDAQ:SPHS READ THE FULL SPHS RESEARCH REPORT Business Update Interim Safety and Efficacy Data for Phase 2b Trial of Topsalysin in Localized Prostate Cancer On SOPHIRIS BIO INC (SPHS) Stock Forum & Discussion - Yahoo By David Bautz, PhD NASDAQ:SPHS READ THE FULL SPHS RESEARCH REPORT Business Update Interim Safety and Efficacy Data for Phase 2b Trial of Topsalysin in Localized Prostate Cancer On

SPHS - Stock quote for SOPHIRIS BIO INC. - MSN Money

Sophiris Bio Inc (SPHS) Nasdaq 12/2/2014 Epirium Bio Appoints Alexander Casdin, Reneo Capital Management Founder, as Chief Financial Officer SPHS Sophiris Bio Inc. Stock Price and Discussion Nov 24, 2020 · Real-time trade and investing ideas on Sophiris Bio Inc. SPHS from the largest community of traders and investors. Rooms Rankings Earnings Calendar Shop. Cancel. Log In. Sign Up. DOW 0.00%. S&P 500 0.00%. NASDAQ 0.00%. Trending now. Sophiris Bio Inc. 0.01 0.00 (0.00%) Watch. Sophiris Bio Inc. SPHS 0.01 0.00 (0.00%) OTC Updated Nov 24, 2020 7:54 SPHS Sophiris Bio Inc. Stock Price and Discussion Nov 24, 2020 · Real-time trade and investing ideas on Sophiris Bio Inc. SPHS from the largest community of traders and investors. Rooms Rankings Earnings Calendar Shop. Cancel. Log In. Sign Up. DOW 0.00%. S&P 500 0.00%. NASDAQ 0.00%. Trending now. Sophiris Bio Inc. 0.01 0.00 (0.00%) Watch. Sophiris Bio Inc. SPHS 0.01 0.00 (0.00%) OTC Updated Nov 24, 2020 7:54

SPHS Sophiris Bio Inc. Profile MarketWatch

SPHS Profile. Company Profile. Sophiris Bio Inc. 1258 Prospect Street. La Jolla, California 92037 . Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. SPHS Stock Price Sophiris Bio Inc. Stock Quote (U.S Nov 25, 2020 · SPHS Complete Sophiris Bio Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. SPHS:Dividend Date & History for Sophiris Bio Inc SPHS:NASDAQ (Stock) Sophiris Bio Inc Dividend policy None Price as of:NOV 13, 04:52 PM EDT $0.01 +0.0 +0.0% Watchlist Overview. Compare. Payout Estimate. New. Payout History. Trading Ideas. News & Research. Company Profile. Home Dividend Stocks Health Care Biotech Pharma Specialty Pharma Sophiris Bio Inc (SPHS) Overview.

SPHS:Dividend Date & History for Sophiris Bio Inc

SPHS:NASDAQ (Stock) Sophiris Bio Inc Dividend policy None Price as of:NOV 13, 04:52 PM EDT $0.01 +0.0 +0.0% Watchlist Overview. Compare. Payout Estimate. New. Payout History. Trading Ideas. News & Research. Company Profile. Home Dividend Stocks Health Care Biotech Pharma Specialty Pharma Sophiris Bio Inc (SPHS) Overview. Sophiris Bio Announces Nasdaq Delisting Nasdaq:SPHSMar 10, 2020 · SAN DIEGO and VANCOUVER, British Columbia, March 10, 2020 (GLOBE NEWSWIRE) -- Sophiris Bio Inc. (NASDAQ:SPHS) (the "Company" or "Sophiris"), a biopharmaceutical company studying topsalysin Sophiris Bio Inc (SPHS) Earnings Report Date NasdaqFind the latest Earnings Report Date for Sophiris Bio Inc (SPHS) at Nasdaq.

Sophiris Bio, Inc. - SPHS - Stock Price Today - Zacks

Nov 17, 2020 · View Sophiris Bio, Inc. SPHS investment & stock information. Get the latest Sophiris Bio, Inc. SPHS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. SPHS Stock Forecast, Price & News (Sophiris Bio) MarketBeatSophiris Bio, Inc. (NASDAQ:SPHS) issued its quarterly earnings results on Thursday, May, 9th. The biopharmaceutical company reported ($0.08) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.10) by $0.02. View Sophiris Bio's earnings history. Who are some of Sophiris Bio's key competitors?

Get Price

We can supply you need sphs nasdaq.